The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

A new study from Tulane University finds that historical race-based lending practices are still impacting health today, linking these discriminatory policies to delays in effective HIV treatment ...

for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. Raltegravir Tablets USP, 600 mg are indicated ...

A virologist at the University of Nebraska-Lincoln, Qingsheng Li, was awarded $3.5 million to advance his work on a vaccine ...

For years, a preventive treatment that can significantly decrease the risk of contracting HIV has been available in Nova ...

Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...

They focus on peptide nanofibrils (PNFs) on magnetic ... Researchers a Step Closer to a Cure for HIV Mar. 26, 2024 — A new study shows virus-like particle can effectively 'shock and kill' latent ...

The National HIV and AIDS Control Programme of the Ghana Health Service has reported over 34,000 new HIV infections detected ...

The government has confirmed it has set aside £11.8bn to compensate victims of the infected blood scandal. More than 30,000 ...

"Our study provides new insights into the numbers and ... The number of US clinicians available to provide HIV prevention and treatment is "substantially shrinking," the survey responses suggested.

The National HIV and AIDS Control Programme of the Ghana Health Service (GHS) has reported over 34,000 new HIV infections ...

The country’s successful rollout of HIV anti-retroviral drugs has lulled many into a false sense of security around ...